The Basement Membrane Proteoglycans Perlecan and Agrin: Something Old, Something New

Current Topics in Membranes

Volumn 76, Issue , 2015, Pages 255-303

  McCarthy, Kevin J ^a  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

Agrin; Chondroitin; Glycosaminoglycan; Heparin; Perlecan; Proteoglycan

Indexed keywords

AGRIN; PERLECAN; PROTEOHEPARAN SULFATE;

ANIMAL; BASEMENT MEMBRANE; CHEMISTRY; GENETICS; HUMAN; METABOLISM;

AGRIN; ANIMALS; BASEMENT MEMBRANE; HEPARAN SULFATE PROTEOGLYCANS; HUMANS;

EID: 84966714176     PISSN: 10635823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ctm.2015.09.001     Document Type: Article

References (236)

1. Abe N., Muragaki Y., Yoshioka H., Inoue H., Ninomiya Y. Identification of a novel collagen chain represented by extensive interruptions in the triple-helical region. Biochemical and Biophysical Research Communications 1993, 196(2):576-582. 10.1006/bbrc.1993.2288.
2. Allen J.M., Bateman J.F., Hansen U., Wilson R., Bruckner P., Owens R.T., et al. WARP is a novel multimeric component of the chondrocyte pericellular matrix that interacts with perlecan. Journal of Biological Chemistry 2006, 281(11):7341-7349. 10.1074/jbc.M513746200.
3. Allen J.M., Brachvogel B., Farlie P.G., Fitzgerald J., Bateman J.F. The extracellular matrix protein WARP is a novel component of a distinct subset of basement membranes. Matrix Biology 2008, 27(4):295-305. 10.1016/j.matbio.2008.01.005.
4. Allen J.M., Zamurs L., Brachvogel B., Schlotzer-Schrehardt U., Hansen U., Lamande S.R., et al. Mice lacking the extracellular matrix protein WARP develop normally but have compromised peripheral nerve structure and function. Journal of Biological Chemistry 2009, 284(18):12020-12030. 10.1074/jbc.M806968200.
5. Annies M., Bittcher G., Ramseger R., Loschinger J., Woll S., Porten E., et al. Clustering transmembrane-agrin induces filopodia-like processes on axons and dendrites. Molecular and Cellular Neuroscience 2006, 31(3):515-524. 10.1016/j.mcn.2005.11.005.
6. Arikawa-Hirasawa E., Le A.H., Nishino I., Nonaka I., Ho N.C., Francomano C.A., et al. Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. American Journal of Human Genetics 2002, 70(5):1368-1375. 10.1086/340390.
7. Arikawa-Hirasawa E., Rossi S.G., Rotundo R.L., Yamada Y. Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice. Nature Neuroscience 2002, 5(2):119-123. 10.1038/nn801.
8. Arikawa-Hirasawa E., Watanabe H., Takami H., Hassell J.R., Yamada Y. Perlecan is essential for cartilage and cephalic development. Nature Genetics 1999, 23(3):354-358. 10.1038/15537.
9. Arikawa-Hirasawa E., Wilcox W.R., Le A.H., Silverman N., Govindraj P., Hassell J.R., et al. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene. Nature Genetics 2001, 27(4):431-434. 10.1038/86941.
10. Bangratz M., Sarrazin N., Devaux J., Zambroni D., Echaniz-Laguna A., Rene F., et al. A mouse model of Schwartz-Jampel syndrome reveals myelinating Schwann cell dysfunction with persistent axonal depolarization in vitro and distal peripheral nerve hyperexcitability when perlecan is lacking. American Journal of Pathology 2012, 180(5):2040-2055. 10.1016/j.ajpath.2012.01.035.
11. Banyai L., Sonderegger P., Patthy L. Agrin binds BMP2, BMP4 and TGFbeta1. PLoS One 2010, 5(5):e10758. 10.1371/journal.pone.0010758.
12. Bateman A., Bennett H.P. The granulin gene family: from cancer to dementia. Bioessays 2009, 31(11):1245-1254. 10.1002/bies.200900086.
13. Bauche S., Boerio D., Davoine C.S., Bernard V., Stum M., Bureau C., et al. Peripheral nerve hyperexcitability with preterminal nerve and neuromuscular junction remodeling is a hallmark of Schwartz-Jampel syndrome. Neuromuscular Disorders 2013, 23(12):998-1009. 10.1016/j.nmd.2013.07.005.
14. Bernfield M.R., Banerjee S.D. Acid mucopolysaccharide (glycosaminoglycan) at the epithelial-mesenchymal interface of mouse embryo salivary glands. Journal of Cell Biology 1972, 52(3):664-673. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=4109689.
15. Bishop J.R., Schuksz M., Esko J.D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007, 446(7139):1030-1037. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17460664.
16. Bix G., Fu J., Gonzalez E.M., Macro L., Barker A., Campbell S., et al. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. Journal of Cell Biology 2004, 166(1):97-109. 10.1083/jcb.200401150.
17. Bork P., Patthy L. The SEA module: a new extracellular domain associated with O-glycosylation. Protein Science 1995, 4(7):1421-1425. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7670383.
18. Brown J.C., Sasaki T., Gohring W., Yamada Y., Timpl R. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans. European Journal of Biochemistry 1997, 250(1):39-46. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/9431988.
19. Burgess R.W., Dickman D.K., Nunez L., Glass D.J., Sanes J.R. Mapping sites responsible for interactions of agrin with neurons. J Neurochem 2002, 83(2):271-284. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/12423238.
20. Burgess R.W., Nguyen Q.T., Son Y.J., Lichtman J.W., Sanes J.R. Alternatively spliced isoforms of nerve- and muscle-derived agrin: their roles at the neuromuscular junction. Neuron 1999, 23(1):33-44. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/10402191.
21. Burgess R.W., Skarnes W.C., Sanes J.R. Agrin isoforms with distinct amino termini: differential expression, localization, and function. Journal of Cell Biology 2000, 151(1):41-52. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11018052.
22. Bezakova G., Ruegg M.A. New insights into the roles of agrin. Nature Reviews Molecular Cell Biology 2003, 4(4):295-308. 10.1038/nrm1074.
23. Campanelli J.T., Gayer G.G., Scheller R.H. Alternative RNA splicing that determines agrin activity regulates binding to heparin and alpha-dystroglycan. Development 1996, 122(5):1663-1672. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8625852.
24. Carlson S.S., Caroni P., Kelly R.B. A nerve terminal anchorage protein from electric organ. Journal of Cell Biology 1986, 103(2):509-520. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/2426282.
25. Carlson S.S., Wight T.N. Nerve terminal anchorage protein 1 (TAP-1) is a chondroitin sulfate proteoglycan: biochemical and electron microscopic characterization. Journal of Cell Biology 1987, 105(6 Pt 2):3075-3086. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/3693407.
26. Caulfield J.P., Farquhar M.G. Distribution of annionic sites in glomerular basement membranes: their possible role in filtration and attachment. Proceedings of the National Academy of Sciences of the United States of America 1976, 73(5):1646-1650. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/1064037.
27. Chakravarti S., Horchar T., Jefferson B., Laurie G.W., Hassell J.R. Recombinant domain III of perlecan promotes cell attachment through its RGDS sequence. Journal of Biological Chemistry 1995, 270(1):404-409. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/7814401.
28. Chakravarti S., Phillips S.L., Hassell J.R. Assignment of the perlecan (heparan sulfate proteoglycan) gene to mouse chromosome 4. Mammalian Genome 1991, 1(4):270-272. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/1686572.
29. Chuang C.Y., Lord M.S., Melrose J., Rees M.D., Knox S.M., Freeman C., et al. Heparan sulfate-dependent signaling of fibroblast growth factor 18 by chondrocyte-derived perlecan. Biochemistry 2010, 49(26):5524-5532. 10.1021/bi1005199.
30. Clarke D.N., Al Ahmad A., Lee B., Parham C., Auckland L., Fertala A., et al. Perlecan domain V induces VEGf secretion in brain endothelial cells through integrin alpha5beta1 and ERK-dependent signaling pathways. PLoS One 2012, 7(9):e45257. 10.1371/journal.pone.0045257.
31. Cohen I.R., Grassel S., Murdoch A.D., Iozzo R.V. Structural characterization of the complete human perlecan gene and its promoter. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(21):10404-10408. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/8234307.
32. Cohn R.H., Banerjee S.D., Bernfield M.R. Basal lamina of embryonic salivary epithelia. Nature of glycosaminoglycan and organization of extracellular materials. Journal of Cell Biology 1977, 73(2):464-478. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=870502.
33. Copley A.L., Scheinthal B.M. Nature of the endoendothelial layer as demonstrated by ruthenium red. Experimental Cell Research 1970, 59(3):491-492. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/4190850.
34. Costell M., Gustafsson E., Aszodi A., Morgelin M., Bloch W., Hunziker E., et al. Perlecan maintains the integrity of cartilage and some basement membranes. Journal of Cell Biology 1999, 147(5):1109-1122. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/10579729.
35. Costell M., Mann K., Yamada Y., Timpl R. Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides. European Journal of Biochemistry 1997, 243(1-2):115-121. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/9030729.
36. Costell M., Sasaki T., Mann K., Yamada Y., Timpl R. Structural characterization of recombinant domain II of the basement membrane proteoglycan perlecan. FEBS Letters 1996, 396(2-3):127-131. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/8914972.
37. Cotman S.L., Halfter W., Cole G.J. Identification of extracellular matrix ligands for the heparan sulfate proteoglycan agrin. Experimental Cell Research 1999, 249(1):54-64. 10.1006/excr.1999.4463.
38. Couchman J.R. Heterogenous distribution of a basement membrane heparan sulfate proteoglycan in rat tissues. Journal of Cell Biology 1987, 105:1901-1916.
39. Couchman J.R., Caterson B., Christner J.E., Baker J.R. Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues. Nature 1984, 307:650-652.
40. Couchman J.R., Woods A., Hook M., Christner J.E. Characterization of a dermatan sulfate proteoglycan synthesized by murine parietal yolk sac (PYS-2) cells. Journal of Biological Chemistry 1985, 260:13755-13762.
41. Daniels M.P. The role of agrin in synaptic development, plasticity and signaling in the central nervous system. Neurochemistry International 2012, 61(6):848-853. 10.1016/j.neuint.2012.02.028.
42. Denzer A.J., Brandenberger R., Gesemann M., Chiquet M., Ruegg M.A. Agrin binds to the nerve-muscle basal lamina via laminin. Journal of Cell Biology 1997, 137(3):671-683. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/9151673.
43. Denzer A.J., Schulthess T., Fauser C., Schumacher B., Kammerer R.A., Engel J., et al. Electron microscopic structure of agrin and mapping of its binding site in laminin-1. EMBO Journal 1998, 17(2):335-343. 10.1093/emboj/17.2.335.
44. Dodge G.R., Kovalszky I., Chu M.L., Hassell J.R., McBride O.W., Yi H.F., et al. Heparan sulfate proteoglycan of human colon: partial molecular cloning, cellular expression, and mapping of the gene (HSPG2) to the short arm of human chromosome 1. Genomics 1991, 10(3):673-680. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/1679749.
45. Dolan M., Horchar T., Rigatti B., Hassell J.R. Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis. Journal of Biological Chemistry 1997, 272(7):4316-4322. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/9020150.
46. Eldridge S., Nalesso G., Ismail H., Vicente-Greco K., Kabouridis P., Ramachandran M., Dell'Accio F. Agrin mediates chondrocyte homeostasis and requires both LRP4 and alpha-dystroglycan to enhance cartilage formation in vitro and in vivo. Annals of the Rheumatic Diseases 2015, 10.1136/annrheumdis-2015-207316.
47. Esko J.D., Kimata K., Lindahl U. Proteoglycans and sulfated glycosaminoglycans 2009, Cold Spring Harbor Press, New York. 2nd ed.
48. Esko J., Lindahl U. Molecular diversity of heparan sulfate. Journal of Clinical Investigation 2001, 108:169-173.
49. Esko J.D., Selleck S.B. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annual Review of Biochemistry 2002, 71:435-471. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12045103.
50. Farach-Carson M.C., Brown A.J., Lynam M., Safran J.B., Carson D.D. A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation. Matrix Biology 2008, 27(2):150-160. 10.1016/j.matbio.2007.09.007.
51. Farach-Carson M.C., Carson D.D. Perlecan-a multifunctional extracellular proteoglycan scaffold. Glycobiology 2007, 17(9):897-905. 10.1093/glycob/cwm043.
52. Farach-Carson M.C., Warren C.R., Harrington D.A., Carson D.D. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders. Matrix Biology 2014, 34:64-79. 10.1016/j.matbio.2013.08.004.
53. Fenger M., Wewer U., Albrechtsen R. Basement membrane heparan sulfate proteoglycan from the L2 rat yolk sac carcinoma. FEBS Letters 1984, 173:75-79.
54. Ferns M.J., Campanelli J.T., Hoch W., Scheller R.H., Hall Z. The ability of agrin to cluster AChRs depends on alternative splicing and on cell surface proteoglycans. Neuron 1993, 11(3):491-502. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/8398142.
55. Folkman J. Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action. Experimental Cell Research 2006, 312(5):594-607. 10.1016/j.yexcr.2005.11.015.
56. French M.M., Smith S.E., Akanbi K., Sanford T., Hecht J., Farach-Carson M.C., et al. Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. Journal of Cell Biology 1999, 145(5):1103-1115. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/10352025.
57. Friedrich M.V., Gohring W., Morgelin M., Brancaccio A., David G., Timpl R. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V. Journal of Molecular Biology 1999, 294(1):259-270. 10.1006/jmbi.1999.3259.
58. Gesemann M., Brancaccio A., Schumacher B., Ruegg M.A. Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. Journal of Biological Chemistry 1998, 273(1):600-605. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/9417121.
59. Gesemann M., Cavalli V., Denzer A.J., Brancaccio A., Schumacher B., Ruegg M.A. Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor. Neuron 1996, 16(4):755-767. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8607994.
60. Gibson K.D., Segen B.J., Audhya T.K. The effect of beta-D-xylosides on chondroitin sulphate biosynthesis in embryonic chicken cartilage in the absence of protein synthesis inhibitors. Biochemical Journal 1977, 162(2):217-233. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/849282.
61. Gibson K.D., Segen B.J., Doller H.J. Changes in chemical composition of chick embryos treated with a beta-xyloside and a lathyrogen. Teratology 1979, 19(3):345-356. 10.1002/tera.1420190311.
62. Gohring W., Sasaki T., Heldin C.H., Timpl R. Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope. European Journal of Biochemistry 1998, 255(1):60-66. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/9692901.
63. Goldberg S., Harvey S.J., Cunningham J., Tryggvason K., Miner J.H. Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane. Nephrology Dialysis Transplantation 2009, 24(7):2044-2051. 10.1093/ndt/gfn758.
64. Gonzalez E.M., Mongiat M., Slater S.J., Baffa R., Iozzo R.V. A novel interaction between perlecan protein core and progranulin: potential effects on tumor growth. Journal of Biological Chemistry 2003, 278(40):38113-38116. 10.1074/jbc.C300310200.
65. Gonzalez E.M., Reed C.C., Bix G., Fu J., Zhang Y., Gopalakrishnan B., et al. BMP-1/tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. Journal of Biological Chemistry 2005, 280(8):7080-7087. 10.1074/jbc.M409841200.
66. Govindraj P., West L., Koob T.J., Neame P., Doege K., Hassell J.R. Isolation and identification of the major heparan sulfate proteoglycans in the developing bovine rib growth plate. Journal of Biological Chemistry 2002, 277(22):19461-19469. 10.1074/jbc.M200786200.
67. Goyal A., Pal N., Concannon M., Paul M., Doran M., Poluzzi C., et al. Endorepellin, the angiostatic module of perlecan, interacts with both the alpha2beta1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism. Journal of Biological Chemistry 2011, 286(29):25947-25962. 10.1074/jbc.M111.243626.
68. Goyal A., Poluzzi C., Willis C.D., Smythies J., Shellard A., Neill T., et al. Endorepellin affects angiogenesis by antagonizing diverse vascular endothelial growth factor receptor 2 (VEGFR2)-evoked signaling pathways: transcriptional repression of hypoxia-inducible factor 1alpha and VEGFA and concurrent inhibition of nuclear factor of activated T cell 1 (NFAT1) activation. Journal of Biological Chemistry 2012, 287(52):43543-43556. 10.1074/jbc.M112.401786.
69. Graham L.D., Whitelock J.M., Underwood P.A. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains. Biochemical and Biophysical Research Communications 1999, 256(3):542-548. 10.1006/bbrc.1999.0377.
70. Gregory J.D., Laurent T.C., Roden L. Enzymatic degradation of chondromucoprotein. Journal of Biological Chemistry 1964, 239:3312-3320. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/14245379.
71. Groffen A.J., Buskens C.A., van Kuppevelt T.H., Veerkamp J.H., Monnens L.A., van den Heuvel L.P. Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. European Journal of Biochemistry 1998, 254(1):123-128. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9652404.
72. Groffen A.J., Ruegg M.A., Dijkman H., van de Velden T.J., Buskens C.A., van den Born J., van den Heuvel L.P. Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. Journal of Histochemistry and Cytochemistry 1998, 46(1):19-27. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9405491.
73. Halfter W., Dong S., Schurer B., Cole G.J. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. Journal of Biological Chemistry 1998, 273(39):25404-25412. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9738008.
74. Hansen U., Allen J.M., White R., Moscibrocki C., Bruckner P., Bateman J.F., et al. WARP interacts with collagen VI-containing microfibrils in the pericellular matrix of human chondrocytes. PLoS One 2012, 7(12):e52793. 10.1371/journal.pone.0052793.
75. Harvey S.V., Jarad G., Cunningham J., Rops A.L., van der Vlag J., Berden J.H., et al. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. American Journal of Pathology 2007, 171(1):139-152.
76. Hassell J.R., Leyshon W.C., Ledbetter S.R., Tyree B., Suzuki S., Kato M., et al. Isolation of two forms of basement membrane proteoglycans. Journal of Biological Chemistry 1985, 260:8098-8105.
77. Hassell J.R., Robey P.G., Barrach H.J., Wilczek J., Rennard S.I., Martin G.R. Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proceedings of the National Academy of Sciences of the United States of America 1980, 77:4504-4508.
78. Hausser H.J., Ruegg M.A., Brenner R.E., Ksiazek I. Agrin is highly expressed by chondrocytes and is required for normal growth. Histochemistry and Cell Biology 2007, 127(4):363-374. 10.1007/s00418-006-0258-2.
79. Hayes A.J., Lord M.S., Smith S.M., Smith M.M., Whitelock J.M., Weiss A.S., et al. Colocalization in vivo and association in vitro of perlecan and elastin. Histochemistry and Cell Biology 2011, 136(4):437-454. 10.1007/s00418-011-0854-7.
80. Helting T. Biosynthesis of heparin. Solubilization and partial purification of uridine diphosphate glucuronic acid: acceptor glucuronosyltransferase from mouse mastocytoma. Journal of Biological Chemistry 1972, 247(13):4327-4332. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/4260846.
81. Helting T., Roden L. Biosynthesis of chondroitin sulfate. II. Glucuronosyl transfer in the formation of the carbohydrate-protein linkage region. Journal of Biological Chemistry 1969, 244(10):2799-2805. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/5770003.
82. Hopf M., Gohring W., Kohfeldt E., Yamada Y., Timpl R. Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin. European Journal of Biochemistry 1999, 259(3):917-925. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/10092882.
83. Hopf M., Gohring W., Mann K., Timpl R. Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan. Journal of Molecular Biology 2001, 311(3):529-541. 10.1006/jmbi.2001.4878.
84. Iozzo R.V. Basement membrane proteoglycans: from cellar to ceiling. Nature Reviews Molecular Cell Biology 2005, 6(8):646-656. 10.1038/nrm1702.
85. Iozzo R.V., Clark C.C. Biosynthesis of proteoglycans by rat embryo parietal yolk sacs in organ culture. Journal of Biological Chemistry 1986, 261(15):6658-6669. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/3084487.
86. Iozzo R.V., Clark C.C. Chondroitin sulfate proteoglycan is a constituent of the basement membrane in the rat embryo parietal yolk sac. Histochemistry 1987, 88(1):23-29. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/3436841.
87. Iozzo R.V., Pillarisetti J., Sharma B., Murdoch A.D., Danielson K.G., Uitto J., et al. Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-beta via a nuclear factor 1-binding element. Journal of Biological Chemistry 1997, 272(8):5219-5228. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/9030592.
88. Iozzo R.V., Zoeller J.J., Nystrom A. Basement membrane proteoglycans: modulators par excellence of cancer growth and angiogenesis. Molecules and Cells 2009, 27(5):503-513. 10.1007/s10059-009-0069-0.
89. Iwata M., Carlson S.S. A large chondroitin sulfate basement membrane-associated proteoglycan exists as a disulfide-stabilized complex of several proteins. Journal of Biological Chemistry 1991, 266(1):323-333. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/1985903.
90. Iwata S., Ito M., Nakata T., Noguchi Y., Okuno T., Ohkawara B., et al. A missense mutation in domain III in HSPG2 in Schwartz-Jampel syndrome compromises secretion of perlecan into the extracellular space. Neuromuscular Disorders 2015, 25(8):667-671. 10.1016/j.nmd.2015.05.002.
91. Jansson L., Lindahl U. Evidence for the existence of a multichain proteoglycan of heparan sulphate. Biochemical Journal 1970, 117(4):699-702. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/4247363.
92. Kabouridis P.S., Pimentel T.A., Brancaleone V., D'Acquisto F., Oliani S.M., Perretti M., et al. Distinct localization of T cell agrin during antigen presentation-evidence for the expression of agrin receptor(s) in antigen-presenting cells. FEBS Journal 2012, 279(13):2368-2380. 10.1111/j.1742-4658.2012.08615.x.
93. Kallunki P., Eddy R.L., Byers M.G., Kestila M., Shows T.B., Tryggvason K. Cloning of human heparan sulfate proteoglycan core protein, assignment of the gene (HSPG2) to 1p36.1-p35 and identification of a BamHI restriction fragment length polymorphism. Genomics 1991, 11(2):389-396. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/1685141.
94. Kallunki P., Tryggvason K. Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. Journal of Cell Biology 1992, 116:559-571.
95. Kammerer R.A., Schulthess T., Landwehr R., Schumacher B., Lustig A., Yurchenco P.D., et al. Interaction of agrin with laminin requires a coiled-coil conformation of the agrin-binding site within the laminin gamma1 chain. EMBO Journal 1999, 18(23):6762-6770. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10581249.
96. Kanke Y., Doller H.J., Segen B.J., Gibson K.D. Development of the biochemical and morphological changes induced by administration of a beta-xyloside to chick embryos. Teratology 1982, 25(1):81-88. 10.1002/tera.1420250111.
97. Kanwar Y.S., Farquhar M.G. Anionic sites in the glomerular basement membrane. In vivo and in vitro localization to the lamina rarae by cationic probes. Journal of Cell Biology 1979, 81:137-153.
98. Kanwar Y.S., Farquhar M.G. Isolation of glycosaminoglycans (heparan sulfate) from glomerular basement membranes. Proceedings of the National Academy of Sciences of the United States of America 1979, 76:4493-4497.
99. Kanwar Y.S., Hascall V.C., Jakubowski M.L., Gibbons J.T. Effect of beta-D-xyloside on the glomerular proteoglycans. I. Biochemical studies. Journal of Cell Biology 1984, 99(2):715-722. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/6746744.
100. Kanwar Y.S., Rosenzweig L.J., Jakubowski M.L. Effect of beta-D-xyloside on the renal glomerular cells. II. Morphological studies. Laboratory Investigation 1987, 56(2):160-169. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/3807315.
101. Khan A.A., Bose C., Yam L.S., Soloski M.J., Rupp F. Physiological regulation of the immunological synapse by agrin. Science 2001, 292(5522):1681-1686. 10.1126/science.1056594.
102. Kim N., Stiegler A.L., Cameron T.O., Hallock P.T., Gomez A.M., Huang J.H., et al. Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell 2008, 135(2):334-342. 10.1016/j.cell.2008.10.002.
103. Kirn-Safran C., Farach-Carson M.C., Carson D.D. Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans. Cellular and Molecular Life Sciences 2009, 66(21):3421-3434. 10.1007/s00018-009-0096-1.
104. Kinnunen A.I., Sormunen R., Elamaa H., Seppinen L., Miller R.T., Ninomiya Y., Pihlajaniemi T. Lack of collagen XVIII long isoforms affects kidney podocytes, whereas the short form is needed in the proximal tubular basement membrane. J Biol Chem 2011, 286(10):7755-7764. 10.1074/jbc.M110.166132.
105. Kivirikko S., Heinamaki P., Rehn M., Honkanen N., Myers J.C., Pihlajaniemi T. Primary structure of the alpha 1 chain of human type XV collagen and exon-intron organization in the 3' region of the corresponding gene. Journal of Biological Chemistry 1994, 269(7):4773-4779. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/8106446.
106. Klein D.J., Brown D.M., Moran A., Oegema T.R., Platt J.L. Chondroitin sulfate proteoglycan synthesis and reutilization of beta-D-xyloside-initiated chondroitin/dermatan sulfate glycosaminoglycans in fetal kidney branching morphogenesis. Developmental Biology 1989, 133(2):515-528. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/2499495.
107. Klein D.J., Brown D.M., Oegema T.R. Glomerular proteoglycans in diabetes. Partial structural characterization and metabolism of de novo synthesized heparan - 35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats. Diabetes 1986, 35:1130-1142.
108. Klein D.J., Brown D.M., Oegema T.R., Brenchely P.E., Anderson J.C., Dickinson M.A.J., et al. Glomerular basement membrane proteoglycans are derived from a large precursor. Journal of Cell Biology 1988, 106:963-970.
109. Knox S.M., Whitelock J.M. Perlecan: how does one molecule do so many things?. Cellular and Molecular Life Sciences 2006, 63(21):2435-2445. 10.1007/s00018-006-6162-z.
110. Kokenyesi R., Silbert J.E. Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells. Biochemical and Biophysical Research Communications 1995, 211(1):262-267. 10.1006/bbrc.1995.1805.
111. Kreuger J., Spillmann D., Li J., Lindahl U. Interactions between heparan sulfate and proteins: the concept of specificity. Journal of Cell Biology 2006, 174(3):323-327.
112. Krusius T., Ruoslahti E. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proceedings of the National Academy of Sciences of the United States of America 1986, 83(20):7683-7687. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/3484330.
113. Kvist A.J., Nystrom A., Hultenby K., Sasaki T., Talts J.F., Aspberg A. The major basement membrane components localize to the chondrocyte pericellular matrix-a cartilage basement membrane equivalent?. Matrix Biology 2008, 27(1):22-33. 10.1016/j.matbio.2007.07.007.
114. Lee B., Clarke D., Al Ahmad A., Kahle M., Parham C., Auckland L., et al. Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. Journal of Clinical Investigation 2011, 121(8):3005-3023. 10.1172/JCI46358.
115. Lelongt B., Makino H., Dalecki T.M., Kanwar Y.S. Role of proteoglycans in renal development. Developmental Biology 1988, 128(2):256-276. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/3294059.
116. Lev R., Spicer S.S. Specific staining of sulphate groups with alcian blue at low Ph. Journal of Histochemistry and Cytochemistry 1964, 12:309. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/14187344.
117. Li D., Clark C.C., Myers J.C. Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. Journal of Biological Chemistry 2000, 275(29):22339-22347. 10.1074/jbc.M000519200.
118. Lin L., McCroskery S., Ross J.M., Chak Y., Neuhuber B., Daniels M.P. Induction of filopodia-like protrusions by transmembrane agrin: role of agrin glycosaminoglycan chains and Rho-family GTPases. Experimental Cell Research 2010, 316(14):2260-2277. 10.1016/j.yexcr.2010.05.006.
119. Lindahl U., Cifonelli J.A., Lindahl B., Roden L. The role of serine in the linkage of heparin to protein. Journal of Biological Chemistry 1965, 240:2817-2820. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/14342300.
120. Lindahl U., Kusche-Gullberg M., Kjellen L. Regulated diversity of heparan sulfate. Journal of Biological Chemistry 1998, 273(39):24979-24982. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9737951.
121. Lindahl U., Roden L. The linkage of heparin to protein. Biochemical and Biophysical Research Communications 1964, 17(3):254-259. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/5862978.
122. Lindahl U., Roden L. The role of galactose and xylose in the linkage of heparin to protein. Journal of Biological Chemistry 1965, 240:2821-2826. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/14342301.
123. Lindahl U., Roden L. The chondroitin 4-sulfate-protein linkage. Journal of Biological Chemistry 1966, 241(9):2113-2119. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/4287762.
124. Lohmander L.S., Hascall V.C., Caplan A.I. Effects of 4-methyl umbelliferyl-beta-D-xylopyranoside on chondrogenesis and proteoglycan synthesis in chick limb bud mesenchymal cell cultures. Journal of Biological Chemistry 1979, 254(20):10551-10561. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/573760.
125. Lord M.S., Jung M., Cheng B., Whitelock J.M. Transcriptional complexity of the HSPG2 gene in the human mast cell line, HMC-1. Matrix Biology 2014, 35:123-131. 10.1016/j.matbio.2013.12.005.
126. Mazzon C., Anselmo A., Cibella J., Soldani C., Destro A., Kim N., et al. The critical role of agrin in the hematopoietic stem cell niche. Blood 2011, 118(10):2733-2742. 10.1182/blood-2011-01-331272.
127. Mazzon C., Anselmo A., Soldani C., Cibella J., Ploia C., Moalli F., et al. Agrin is required for survival and function of monocytic cells. Blood 2012, 119(23):5502-5511. 10.1182/blood-2011-09-382812.
128. McCarthy K.J., Accavitti M.A., Couchman J.R. Immunological characterization of a basement membrane-specific chondroitin sulfate proteoglycan. Journal of Cell Biology 1989, 109:3187-3198. Retrieved from. http://file://localhost/Users/kevinmcc/Desktop/PDF%20Articles/3%20Proteoglycans/BM-CSPG%20article%20original.pdf.
129. McCarthy K.J., Bynum K., St John P.L., Abrahamson D.R., Couchman J.R. Basement membrane proteoglycans in glomerular morphogenesis: chondroitin sulfate proteoglycan is temporally and spatially restricted during development. Journal of Histochemistry and Cytochemistry 1993, 41(3):401-414. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/8429203.
130. McCarthy K.J., Bynum K., St John P.L., Abrahamson J.R., Couchman J.R. Basement membrane specific chondroitin sulfate proteoglycan is abnormally associated with the glomerular capillary basement membrane in diabetic rats. Journal of Histochemistry and Cytochemistry 1994, 42:473-484.
131. McCarthy K.J., Wassenhove-McCarthy D.J. The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans. Microsc Microanal 2012, 18(1):3-21. doi:S1431927611012682 [pii]10.1017/S1431927611012682.
132. McCroskery S., Chaudhry A., Lin L., Daniels M.P. Transmembrane agrin regulates filopodia in rat hippocampal neurons in culture. Molecular and Cellular Neuroscience 2006, 33(1):15-28. 10.1016/j.mcn.2006.06.004.
133. McLean J. The thromboplastic action of Cephalin. American Journal of Physiology 1916, 41:250-257.
134. Melrose J., Hayes A.J., Whitelock J.M., Little C.B. Perlecan, the "jack of all trades" proteoglycan of cartilaginous weight-bearing connective tissues. Bioessays 2008, 30(5):457-469. 10.1002/bies.20748.
135. Melrose J., Roughley P., Knox S., Smith S., Lord M., Whitelock J. The structure, location, and function of perlecan, a prominent pericellular proteoglycan of fetal, postnatal, and mature hyaline cartilages. Journal of Biological Chemistry 2006, 281(48):36905-36914. 10.1074/jbc.M608462200.
136. Miettinen A., Stow J.L., Mentone S., Farquhar M.G. Antibodies to basement membrane heparan sulfate proteoglycans bind to the lamina rarae of the glomerular basement membrane (GBM) and induce subepithelial basement membrane thickening. Journal of Experimental Medicine 1986, 163:1064-1084.
137. Miosge N., Simniok T., Sprysch P., Herken R. The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo. Journal of Histochemistry and Cytochemistry 2003, 51(3):285-296. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/12588956.
138. Mongiat M., Otto J., Oldershaw R., Ferrer F., Sato J.D., Iozzo R.V. Fibroblast growth factor-binding protein is a novel partner for perlecan protein core. Journal of Biological Chemistry 2001, 276(13):10263-10271. 10.1074/jbc.M011493200.
139. Mongiat M., Sweeney S.M., San Antonio J.D., Fu J., Iozzo R.V. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. Journal of Biological Chemistry 2003, 278(6):4238-4249. 10.1074/jbc.M210445200.
140. Mongiat M., Taylor K., Otto J., Aho S., Uitto J., Whitelock J.M., et al. The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. Journal of Biological Chemistry 2000, 275(10):7095-7100. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/10702276.
141. Moore C.J., Winder S.J. Dystroglycan versatility in cell adhesion: a tale of multiple motifs. Cell Communication Signal 2010, 8:3. 10.1186/1478-811X-8-3.
142. Morita H., Yoshimura A., Inui K., Ideura T., Watanabe H., Wang L., et al. Heparan sulfate of perlecan is involved in glomerular filtration. Journal of the American Society of Nephrology 2005, 16:1703-1710.
143. Morriss-Kay G.M., Crutch B. Culture of rat embryos with beta-D-xyloside: evidence of a role for proteoglycans in neurulation. Journal of Anatomy 1982, 134(Pt 3):491-506. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/6809722.
144. Muller G. [Demonstration of acid mucopolysaccharides by toluidin blue metachromasia, alcian blue staining, PAS reaction and the ferrihydroxidesol-PAS reaction]. Acta Histochemica 1959, 6(5-8):218-224. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/13649222.
145. Multhaupt H.A., Yoneda A., Whiteford J.R., Oh E.S., Lee W., Couchman J.R. Syndecan signaling: when, where and why?. Journal of Physiology and Pharmacology 2009, 60(Suppl 4):31-38. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/20083849.
146. Muragaki Y., Abe N., Ninomiya Y., Olsen B.R., Ooshima A. The human alpha 1(XV) collagen chain contains a large amino-terminal non-triple helical domain with a tandem repeat structure and homology to alpha 1(XVIII) collagen. Journal of Biological Chemistry 1994, 269(6):4042-4046. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/8307960.
147. Murdoch A.D., Dodge G.R., Cohen I., Tuan R.S., Iozzo R.V. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. Journal of Biological Chemistry 1992, 267(12):8544-8557. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/1569102.
148. Myers J.C., Kivirikko S., Gordon M.K., Dion A.S., Pihlajaniemi T. Identification of a previously unknown human collagen chain, alpha 1(XV), characterized by extensive interruptions in the triple-helical region. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(21):10144-10148. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/1279671.
149. Neumann F.R., Bittcher G., Annies M., Schumacher B., Kroger S., Ruegg M.A. An alternative amino-terminus expressed in the central nervous system converts agrin to a type II transmembrane protein. Molecular and Cellular Neuroscience 2001, 17(1):208-225. 10.1006/mcne.2000.0932.
150. Nicole S., Davoine C.S., Topaloglu H., Cattolico L., Barral D., Beighton P., et al. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nature Genetics 2000, 26(4):480-483. 10.1038/82638.
151. Nitkin R.M., Smith M.A., Magill C., Fallon J.R., Yao Y.M., Wallace B.G., et al. Identification of agrin, a synaptic organizing protein from Torpedo electric organ. Journal of Cell Biology 1987, 105(6 Pt 1):2471-2478. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/2826489.
152. Ngo S.T., Noakes P.G., Phillips W.D. Neural agrin: a synaptic stabiliser. The International Journal of Biochemistry and Cell Biology 2007, 39(5):863-867. 10.1016/j.biocel.2006.10.012.
153. Nonaka R., Iesaki T., de Vega S., Daida H., Okada T., Sasaki T., et al. Perlecan deficiency causes endothelial dysfunction by reducing the expression of endothelial nitric oxide synthase. Physiological Reports 2015, 3(1). 10.14814/phy2.12272.
154. Noonan D.M., Fulle A., Valente P., Cai S., Horigan E., Sasaki M., et al. The complete sequence of Perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. Journal of Biological Chemistry 1991, 266:22939-22947.
155. Noonan D.M., Hassell J.R. Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms. Kidney International 1993, 43(1):53-60. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/8433569.
156. Noonan D.M., Horigan E.A., Ledbetter S.R., Vogeli G., Sasaki M., Yamada Y., et al. Identification of cDNA clones encoding different domains of the basement membrane heparan sulfate proteoglycan. Journal of Biological Chemistry 1988, 263(31):16379-16387. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/2972708.
157. Nystrom A., Shaik Z.P., Gullberg D., Krieg T., Eckes B., Zent R., et al. Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity. Blood 2009, 114(23):4897-4906. 10.1182/blood-2009-02-207134.
158. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88(2):277-285. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/9008168.
159. O'Toole J.J., Deyst K.A., Bowe M.A., Nastuk M.A., McKechnie B.A., Fallon J.R. Alternative splicing of agrin regulates its binding to heparin alpha-dystroglycan, and the cell surface. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(14):7369-7374. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/8693000.
160. Oh S.P., Kamagata Y., Muragaki Y., Timmons S., Ooshima A., Olsen B.R. Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proceedings of the National Academy of Sciences of the United States of America 1994, 91(10):4229-4233. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/8183893.
161. Okayama M., Kimata K., Suzuki S. The influence of p-nitrophenyl beta-d-xyloside on the synthesis of proteochondroitin sulfate by slices of embryonic chick cartilage. Journal of Biochemistry 1973, 74(5):1069-1073. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/4770369.
162. Olsen B.R. Life without perlecan has its problems. Journal of Cell Biology 1999, 147(5):909-912. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/10579711.
163. Oohira A., Nogami H., Nakanishi Y. Abnormal overgrowth of chick embryos treated with p-nitrophenyl beta-D-xyloside at early stages of development. Journal of Embryology & Experimental Morphology 1981, 61:221-232. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/7264543.
164. Oohira A., Wight T.N., McPherson J., Bornstein P. Biochemical and ultrastructural studies of proteoheparan sulfates synthesized by PYS-2, a basement membrane-producing cell line. Journal of Cell Biology 1982, 92(2):357-367. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/6174529.
165. Orkin R.W., Gehron P., McGoodwin E.B., Martin G.R., Valentine T., Swarm R. A murine tumor producing a matrix of basement membrane. Journal of Experimental Medicine 1977, 145(1):204-220. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/830788.
166. Platt J.L., Brown D.M., Granlund K., Oegema T.R., Klein D.J. Proteoglycan metabolism associated with mouse metanephric development: morphologic and biochemical effects of beta-D-xyloside. Developmental Biology 1987, 123(2):293-306. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/3653508.
167. Porten E., Seliger B., Schneider V.A., Woll S., Stangel D., Ramseger R., et al. The process-inducing activity of transmembrane agrin requires follistatin-like domains. Journal of Biological Chemistry 2010, 285(5):3114-3125. 10.1074/jbc.M109.039420.
168. Raats C.J., Bakker M.A., Hoch W., Tamboer W.P., Groffen A.J., van den Heuvel L.P., et al. Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. Journal of Biological Chemistry 1998, 273(28):17832-17838. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9651386.
169. Raats C.J., Luca M.E., Bakker M.A., Van Der Wal A., Heeringa P., Van Goor H., et al. Reduction in glomerular heparan sulfate correlates with complement deposition and albuminuria in active Heymann nephritis. Journal of the American Society of Nephrology 1999, 10(8):1689-1699. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10446936.
170. Rada J.A., Carlson E.C. Electron microscopic histochemical and immunochemical analyses of heparan sulfate proteoglycan distribution in renal glomerular basement membranes. Histology and Histopathology 1991, 6(2):149-160. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/1724933.
171. Rada J.A., Carlson E.C. Anionic site and immunogold quantitation of heparan sulfate proteoglycans in glomerular basement membranes of puromycin aminonucleoside nephrotic rats. Anatomical Record 1991, 231:35-47.
172. Rambourg A., Leblond C.P. Staining of basement membranes and associated structures by the periodic acid-Schiff and periodicacid-silver methenamine techniques. Journal of Ultrastructure Research 1967, 20(3):306-309. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/4169782.
173. Ramseger R., White R., Kroger S. Transmembrane form agrin-induced process formation requires lipid rafts and the activation of Fyn and MAPK. Journal of Biological Chemistry 2009, 284(12):7697-7705. 10.1074/jbc.M806719200.
174. Rennke H.G., Cotran R.S., Venkatachalam M.A. Role of molecular charge in glomerular permeability. Tracer studies with cationized ferritins. Journal of Cell Biology 1975, 67(3):638-646. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1202017.
175. Rennke H.G., Venkatachalam M.A. Glomerular permeability: in vivo tracer studies with polyanionic and polycationic ferritins. Kidney International 1977, 11(1):44-53. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=839653.
176. Rizzoli C., Gliozzi M.A. [Alcian blue 8 G.N. staining of mucopolysaccharide acids separated by paper electrophoresis]. Bollettino Societa Italiana Biologia Sperimentale 1955, 31(5):426-428. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/13269460.
177. Rossi M., Morita H., Sormunen R., Airenne S., Kreivi M., Wang L., et al. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO Journal 2003, 22(2):236-245.
178. Ruegg M.A., Tsim K.W., Horton S.E., Kroger S., Escher G., Gensch E.M., et al. The agrin gene codes for a family of basal lamina proteins that differ in function and distribution. Neuron 1992, 8(4):691-699. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/1314621.
179. Rupp F., Ozcelik T., Linial M., Peterson K., Francke U., Scheller R. Structure and chromosomal localization of the mammalian agrin gene. Journal of Neuroscience 1992, 12(9):3535-3544. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/1326608.
180. Rupp F., Payan D.G., Magill-Solc C., Cowan D.M., Scheller R.H. Structure and expression of a rat agrin. Neuron 1991, 6(5):811-823. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/1851019.
181. Saarela J., Rehn M., Oikarinen A., Autio-Harmainen H., Pihlajaniemi T. The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. American Journal of Pathology 1998, 153(2):611-626. 10.1016/S0002-9440(10)65603-9.
182. Sarras M.P., Madden M.E., Zhang X.M., Gunwar S., Huff J.K., Hudson B.G. Extracellular matrix (mesoglea) of Hydra vulgaris. I. Isolation and characterization. Developmental Biology 1991, 148(2):481-494. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/1743396.
183. Sarras M.P., Meador D., Zhang X.M. Extracellular matrix (mesoglea) of Hydra vulgaris. II. Influence of collagen and proteoglycan components on head regeneration. Developmental Biology 1991, 148(2):495-500. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/1743397.
184. Sasaki T., Costell M., Mann K., Timpl R. Inhibition of glycosaminoglycan modification of perlecan domain I by site-directed mutagenesis changes protease sensitivity and laminin-1 binding activity. FEBS Letters 1998, 435(2-3):169-172. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/9762901.
185. Sato Y., Shimono C., Li S., Nakano I., Norioka N., Sugiura N., et al. Nephronectin binds to heparan sulfate proteoglycans via its MAM domain. Matrix Biology 2013, 32(3-4):188-195. 10.1016/j.matbio.2013.01.005.
186. Schulze B., Sasaki T., Costell M., Mann K., Timpl R. Structural and cell-adhesive properties of three recombinant fragments derived from perlecan domain III. Matrix Biology 1996, 15(5):349-357. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/8981331.
187. Schwartz N.B. Chondroitin sulfate glycosyltransferases in cultured chondrocytes. Turnover, oscillatory change during growth, and suppression by 5-bromodeoxyuridine. Journal of Biological Chemistry 1976, 251(11):3346-3351. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/945267.
188. Schwartz N.B. Regulation of chondroitin sulfate synthesis. Effect of beta-xylosides on synthesis of chondroitin sulfate proteoglycan, chondroitin sulfate chains, and core protein. Journal of Biological Chemistry 1977, 252(18):6316-6321. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/561070.
189. Shu C., Smith S.S., Little C.B., Melrose J. Comparative immunolocalisation of perlecan, heparan sulphate, fibroblast growth factor-18, and fibroblast growth factor receptor-3 and their prospective roles in chondrogenic and osteogenic development of the human foetal spine. European Spine Journal 2013, 22(8):1774-1784. 10.1007/s00586-013-2680-1.
190. Smith C.I., Hilfer S.R., Searls R.L., Nathanson M.A., Allodoli M.D. Effects of beta-D-xyloside on differentiation of the respiratory epithelium in the fetal mouse lung. Developmental Biology 1990, 138(1):42-52. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/2307288.
191. Smith C.I., Webster E.H., Nathanson M.A., Searls R.L., Hilfer S.R. Altered patterns of proteoglycan deposition during maturation of the fetal mouse lung. Cell Differentiation and Development 1990, 32(2):83-96. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/2128042.
192. Smith S.M., West L.A., Govindraj P., Zhang X., Ornitz D.M., Hassell J.R. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors. Matrix Biology 2007, 26(3):175-184. 10.1016/j.matbio.2006.10.012.
193. Smith S.M., West L.A., Hassell J.R. The core protein of growth plate perlecan binds FGF-18 and alters its mitogenic effect on chondrocytes. Archives of Biochemistry and Biophysics 2007, 468(2):244-251. 10.1016/j.abb.2007.10.006.
194. Smith M.A., Yao Y.M., Reist N.E., Magill C., Wallace B.G., McMahan U.J. Identification of agrin in electric organ extracts and localization of agrin-like molecules in muscle and central nervous system. Journal of Experimental Biology 1987, 132:223-230. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/2828510.
195. Spooner B.S., Bassett K., Stokes B. Sulfated glycosaminoglycan deposition and processing at the basal epithelial surface in branching and beta-D-xyloside-inhibited embryonic salivary glands. Developmental Biology 1985, 109(1):177-183. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/3987960.
196. Spooner B.S., Paulsen A., Sullins M.S. beta-Xyloside effects on basal lamina structure and anionic site distribution the embryonic mouse submandibular salivary gland. Archives of Oral Biology 1989, 34(7):541-549. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/2480774.
197. Stearns K., Goetinck P.F. Stimulation of chondroitin sulfate synthesis by beta-D-xyloside in chondrocytes of the proteoglycan deficient mutant nanomelia. Journal of Cellular Physiology 1979, 100(1):33-38. 10.1002/jcp.1041000104.
198. Stow J.L., Glasgow E.F., Handley C.J., Hascall V.C. Biosynthesis of proteoglycans by isolated rabbit glomeruli. Archives of Biochemistry and Biophysics 1983, 225(2):950-957. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/6625617.
199. Stow J.L., Sawada H., Farquhar M.G. Basement membrane heparan sulfate proteoglycans are concentrated in the lamina rarae and in podocytes of the rat renal glomerulus. Proceedings of the National Academy of Sciences of the United States of America 1985, 82:3296-3300.
200. Suleiman H., Zhang L., Roth R., Heuser J.E., Miner J.H., Shaw A.S., et al. Nanoscale protein architecture of the kidney glomerular basement membrane. Elife 2013, 2:e01149. 10.7554/eLife.01149.
201. Sugahara K., Mikami T., Uyama T., Mizuguchi S., Nomura K., Kitagawa H. Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Current Opinion in Structural Biology 2003, 13(5):612-620. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/14568617.
202. SundarRaj N., Fite D., Ledbetter S., Chakravarti S., Hassell J.R. Perlecan is a component of cartilage matrix and promotes chondrocyte attachment. Journal of Cell Science 1995, 108(Pt 7):2663-2672. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/7593307.
203. Talts J.F., Andac Z., Gohring W., Brancaccio A., Timpl R. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO Journal 1999, 18(4):863-870. 10.1093/emboj/18.4.863.
204. Tapanadechopone P., Hassell J.R., Rigatti B., Couchman J.R. Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan. Biochemical and Biophysical Research Communications 1999, 265(3):680-690. pii:S0006-291X(99)91714-X. 10.1006/bbrc.1999.1714.
205. Thompson H.A., Spooner B.S. Inhibition of branching morphogenesis and alteration of glycosaminoglycan biosynthesis in salivary glands treated with beta-D-xyloside. Developmental Biology 1982, 89(2):417-424. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/7056440.
206. Thompson H.A., Spooner B.S. Proteoglycan and glycosaminoglycan synthesis in embryonic mouse salivary glands: effects of beta-D-xyloside, an inhibitor of branching morphogenesis. Journal of Cell Biology 1983, 96(5):1443-1450. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/6841454.
207. Tiedemann K., Sasaki T., Gustafsson E., Gohring W., Batge B., Notbohm H., et al. Microfibrils at basement membrane zones interact with perlecan via fibrillin-1. Journal of Biological Chemistry 2005, 280(12):11404-11412. 10.1074/jbc.M409882200.
208. Toole B.P., Lowther D.A. The isolation of a dermatan sulphate-protein complex from bovine heart valves. Biochimica et Biophysica Acta 1965, 101(3):364-366. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/4222033.
209. Tsen G., Halfter W., Kroger S., Cole G.J. Agrin is a heparan sulfate proteoglycan. Journal of Biological Chemistry 1995, 270(7):3392-3399. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/7852425.
210. Tyree B., Horigan E.A., Klippenstein D.L., Hassell J.R. Heterogeneity of heparan sulfate proteoglycans synthesized by PYS-2 cells. Archives of Biochemistry and Biophysics 1984, 231(2):328-335. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/6233937.
211. Van Den Born J., Van Den Heuvel L.P.W.J., Bakker M.A.H., Veerkamp J.H., Assmann K.J.M., Berden J.H.M. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney International 1992, 411:115-123.
212. Vialli M. [Use of Alcian blue 8 GS in the study of mucopolysaccharides]. Bollettino Societa Italiana Biologia Sperimentale 1951, 27(4):597-599. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/14869481.
213. Vincent T.L., McLean C.J., Full L.E., Peston D., Saklatvala J. FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage, where it acts as a chondrocyte mechanotransducer. Osteoarthritis Cartilage 2007, 15(7):752-763. 10.1016/j.joca.2007.01.021.
214. Wang H., Julenius K., Hryhorenko J., Hagen F.K. Systematic analysis of proteoglycan modification sites in Caenorhabditis elegans by scanning mutagenesis. Journal of Biological Chemistry 2007, 282(19):14586-14597. 10.1074/jbc.M609193200.
215. Warren C.R., Grindel B.J., Francis L., Carson D.D., Farach-Carson M.C. Transcriptional activation by NFkappaB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment. Journal of Cellular Biochemistry 2014, 115(7):1322-1333. 10.1002/jcb.24788.
216. Wewer U. Characterization of a rat yolk sac carcinoma cell line. Developmental Biology 1982, 93:416-421.
217. Wewer U.M., Albrechtsen R., Hassell J.R. Heparan sulfate proteoglycans made by different basement-membrane-producing tumors have immunological and structural similarities. Differentiation 1985, 30(1):61-67. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/2936642.
218. Whitelock J.M., Melrose J., Iozzo R.V. Diverse cell signaling events modulated by perlecan. Biochemistry 2008, 47(43):11174-11183. 10.1021/bi8013938.
219. Wight T.N., Ross R. Proteoglycans in primate arteries. I. Ultrastructural localization and distribution in the intima. Journal of Cell Biology 1975, 67(3):660-674. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/53234.
220. Willis C.D., Poluzzi C., Mongiat M., Iozzo R.V. Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells. FEBS Journal 2013, 280(10):2271-2284. 10.1111/febs.12164.
221. Wilusz R.E., Defrate L.E., Guilak F. A biomechanical role for perlecan in the pericellular matrix of articular cartilage. Matrix Biology 2012, 31(6):320-327. 10.1016/j.matbio.2012.05.002.
222. Winzen U., Cole G.J., Halfter W. Agrin is a chimeric proteoglycan with attachment sites for heparan sulfate/chondroitin sulfate located in two multiple serine-glycine clusters. Journal of Biological Chemistry 2003, 278(32):30106-30114.
223. Wislocki G.B., Fawcett D.W., Dempsey E.W. Staining of stratified squamous epithelium of mucous membranes and skin of man and monkey by the periodic acid-Schiff method. Anatomical Record 1951, 110(3):359-375. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/14868888.
224. Woodall B.P., Nystrom A., Iozzo R.A., Eble J.A., Niland S., Krieg T., et al. Integrin alpha2beta1 is the required receptor for endorepellin angiostatic activity. Journal of Biological Chemistry 2008, 283(4):2335-2343. 10.1074/jbc.M708364200.
225. Xu Y.X., Ashline D., Liu L., Tassa C., Shaw S.Y., Ravid K., et al. The glycosylation-dependent interaction of perlecan core protein with LDL: implications for atherosclerosis. Journal of Lipid Research 2015, 56(2):266-276. 10.1194/jlr.M053017.
226. Xu Z., Ichikawa N., Kosaki K., Yamada Y., Sasaki T., Sakai L.Y., et al. Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition. Matrix Biology 2010, 29(6):461-470. 10.1016/j.matbio.2010.06.001.
227. Yamada K. Staining of sulphated polysaccharides by means of alcian blue. Nature 1963, 198:799-800. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/14002231.
228. Yamada H., Denzer A.J., Hori H., Tanaka T., Anderson L.V., Fujita S., et al. Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane. Journal of Biological Chemistry 1996, 271(38):23418-23423. Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/8798547.
229. Yamada S., Morimoto H., Fujisawa T., Sugahara K. Glycosaminoglycans in Hydra magnipapillata (Hydrozoa, Cnidaria): demonstration of chondroitin in the developing nematocyst, the sting organelle, and structural characterization of glycosaminoglycans. Glycobiology 2007, 17(8):886-894. 10.1093/glycob/cwm051.
230. Yard B.A., Kahlert S., Engelleiter R., Resch S., Waldherr R., Groffen A.J., et al. Decreased glomerular expression of agrin in diabetic nephropathy and podocytes, cultured in high glucose medium. Experimental Nephrology 2001, 9(3):214-222. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11340306.
231. Zhang W., Coldefy A.S., Hubbard S.R., Burden S.J. Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK). Journal of Biological Chemistry 2011, 286(47):40624-40630. 10.1074/jbc.M111.279307.
232. Zhang L., David G., Esko J.D. Repetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycans. Journal of Biological Chemistry 1995, 270(45):27127-27135. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7592967.
233. Zhang L., Esko J.D. Amino acid determinants that drive heparan sulfate assembly in a proteoglycan. Journal of Biological Chemistry 1994, 269(30):19295-19299. Retrieved from. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8034692.
234. Zhang B., Luo S., Wang Q., Suzuki T., Xiong W.C., Mei L. LRP4 serves as a coreceptor of agrin. Neuron 2008, 60(2):285-297. 10.1016/j.neuron.2008.10.006.
235. Zhou Z., Wang J., Cao R., Morita H., Soininen R., Chan K.M., et al. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Research 2004, 64(14):4699-4702. 10.1158/0008-5472.CAN-04-0810.
236. Zhang J., Wang Y., Chu Y., Su L., Gong Y., Zhang R., et al. Agrin is involved in lymphocytes activation that is mediated by alpha-dystroglycan. FASEB Journal 2006, 20(1):50-58. 10.1096/fj.04-3303com.